Transcutaneous Nerve Stimulator For Adhd
FDA product code QGL · 4 cleared devices
Class 2
Neurology
- Regulation
- 21 CFR 882.5898
- Review panel
- NE
- Implant
- No
- Life sustaining
- No
- Third party review
- No
- GMP exempt
- No
- Clearance span
- 2023-02-12 – 2025-01-16
A transcutaneous electrical nerve stimulator for Attention Deficit Hyperactivity Disorder (ADHD) is a prescription device that stimulates transcutaneously or percutaneously through electrodes placed on the forehead.
QGL
2025-01-16
QGL
2024-08-28
BT-1000
View details →
QGL
2024-01-16
Generation 2.0 Monarch external Trigeminal Nerve Stimulation (eTNS) System®
View details →
QGL
2023-02-12
SMILE
View details →No matching devices.
Advertisement